Nuclear factor erythroid 2-related factor 2, Cell Signaling Technology, 12721

Our team has carried out deep research in the published scientific literature to identify papers and reports using antibodies directed against human nuclear factor erythroid 2-related factor 2 (NRF2) and followed up by extraction and evaluation of the available data to assess its performance according to pAbmAbs rating criteria. YCharOS is here conducting a large head-to-head study comparing 17 commercial research antibodies against human nuclear factor erythroid 2-related factor 2 (NRF2) encoded by NFE2L2. This antibody was exclusively tested in flow cytometry (WT and KO cells) according to YCharOS standard protocols (see reference). flow cytometry using 12721 (1:11000 ab dilution) showed overlapping fluorescence intensity distributions for untreated WT and KO cells, with no visible shift between the two populations. When stimulated with MG-132 a right shift in WT cells were observed.